| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |